On-Site, Reponsive and Less Invasive Drug Testing In Corrective Services

惩教服务中的现场、反应灵敏且侵入性较小的药物测试

• 批准号: IE230100564
• 负责人: Dr David Rudd
• 金额: $ 25.2万
• 依托单位: Monash University
• 依托单位国家: 澳大利亚
• 项目类别: Early Career Industry Fellowships
• 财政年份: 2023
• 资助国家: 澳大利亚
• 起止时间: 2023-07-01 至 2025-06-30
• 项目状态: 未结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/IE230100564
• 关键词: Site; Reponsive; Less; Invasive; Drug

This project aims to develop a new drug screening system using nanomaterials interfaced with advanced mass spectrometry to improve testing speed, cost, and accuracy, and minimise the distress associated with current drug testing programs within corrective services. Currently, testing programs are costly, with confirmation taking multiple weeks, preventing appropriate responses to drug use and support service recommendations. Additionally, vulnerable people in custody or on corrective orders find conventional urine testing distressing, especially when previously exposed to sexual violence. New accurate, rapid saliva testing on-site will revolutionise drug monitoring and provide an Australian designed solution for correctional jurisdictions.

该项目旨在开发一种新的药物筛选系统，使用纳米材料与先进的质谱技术相结合，以提高测试速度，成本和准确性，并最大限度地减少与纠正服务中当前药物测试计划相关的痛苦。目前，检测项目成本高昂，确认需要数周时间，无法对药物使用和支持服务建议做出适当反应。此外，被拘留或接受矫正命令的弱势群体发现常规尿检令人痛苦，特别是在以前遭受性暴力的情况下。新的准确、快速的现场唾液检测将彻底改变药物监测，并为矫正司法管辖区提供澳大利亚设计的解决方案。